The antibody against γ-H2A.X selectively enriches nucleosomes carrying the phosphorylated histone mark from fragmented chromatin. DNA recovered from this enriched fraction represents genomic regions associated with that signal, while the resulting PCR or sequencing data identify their locations. This connection between antibody selectivity and DNA recovery allows biochemical chromatin changes to be examined at specific genomic loci.
Fixation preserves chromatin-associated relationships at the time cells are collected, whereas fragmentation makes the chromatin suitable for immunoprecipitation and locus-level analysis. Together, these steps help retain the distribution of γ-H2A.X while producing DNA fragments that can be recovered after antibody enrichment. The resulting material supports comparison of damage-associated chromatin patterns between experimental conditions.
Differences in recovered γ-H2A.X-associated DNA can indicate that DNA-damage patterns or repair-associated chromatin changes differ between conditions. Comparing signal at genomic regions helps connect a biochemical response with particular loci rather than viewing damage only as a global cellular measurement. This makes the assay useful for examining how genome damage and repair processes vary across experiments.
A typical workflow fixes cells, fragments their chromatin, and uses an antibody against γ-H2A.X to enrich marked nucleosomes and the DNA associated with them. The recovered DNA is then identified by PCR for selected regions or by sequencing for broader genomic analysis. Researchers can compare these measurements across conditions to evaluate changes in damage-associated chromatin.
PCR is suitable when the analysis focuses on selected genomic regions and the goal is to compare γ-H2A.X-associated DNA at defined loci. Sequencing provides a broader view by identifying recovered DNA across the genome. Thus, the choice depends on whether the experiment asks a targeted question about particular regions or seeks a wider map of damage-associated chromatin.
The assay links a biochemical histone modification to its genomic location, providing a way to study genome damage in chromatin context. Applications described for this approach include comparing DNA-damage patterns, assessing repair-associated chromatin changes, and investigating genome stability and DNA repair. It also supports cancer biology studies where altered damage responses can be evaluated across experimental conditions.